Notably, TCGA data suggests that KDM4B is downregulated in multiple human cancers, negative correlated with the majority of immune cell infiltration but positive correlated with cancer prognosis in melanoma, indicating that tumors may evade immune surveillance by suppressing the KDM4B–cGAS signaling pathway. Here, KDM4B is linked to melanoma.